Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
about
CIViC databaseAntiestrogens: structure-activity relationships and use in breast cancer treatmentAccurate computation of survival statistics in genome-wide studiesSteroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.8p deletion is strongly linked to poor prognosis in breast cancer.Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer.MRTF potentiates TEAD-YAP transcriptional activity causing metastasis.Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancersCombinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition.Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.The effects of bufadienolides on HER2 overexpressing breast cancer cells.A novel isolation method for cancer prognostic factors via the p53 pathway by a combination of in vitro and in silico analyses.
P2860
Q27612411-A57CBFBA-83DC-4B08-908E-34781D43C896Q28077245-03D08FA4-3141-4797-BBBD-9BD6D7F9092FQ35581820-40267096-69EB-4C34-8A96-63BC0DF59A6CQ35796826-54758BE1-C6C4-4910-BFDD-4F6CAF4FFDC4Q36214952-55CB358B-08A0-44E1-9CE4-47A0F7DC36BFQ36912137-985BC99F-B52A-4DDE-B8FD-F7F7C3002824Q38719315-FC463EAD-6B2B-415E-87E8-110B5C60E058Q38724065-64EFA211-DF7A-437E-B008-5DE0D41F3BC3Q38775916-379DBB3B-103C-4CF3-9AFD-D4572F7DC2B6Q41305086-7C51B4D2-2DD2-4AC4-978D-1354A09A0C53Q42500574-1073C8CB-69B4-47FA-9C12-AFB1C65B8446Q47101055-12803BC8-801C-4812-8BEB-E6B241B28363Q48213165-BA045017-B492-4073-8BFC-8AD929C47B04Q53805460-CE4BA172-C868-4548-B433-0D46E25D7879Q55252904-9FBD81E6-F128-4863-96CF-D4635E3E45FF
P2860
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@ast
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@en
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@nl
type
label
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@ast
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@en
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@nl
prefLabel
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@ast
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@en
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@nl
P2093
P2860
P1476
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
@en
P2093
L Terracciano
M Choschzick
P2860
P2888
P304
P356
10.1007/S10549-013-2406-4
P407
P577
2013-02-01T00:00:00Z
P6179
1008872204